In Brief: Micro Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics: Launches ProStream multiple sidehole infusion wire for use in delivering pharmacologic agents into the peripheral vasculature. The device, cleared by FDA Jan. 2, uses a "fixed hub" design and an "integrated inner core wire" for easier placement into peripheral vessels, the firm explains. ProStream, which can be used in conjunction with Micro's Cragg-McNamara valved infusion catheters, will be marketed and sold in the U.S. through the firm's eight-person direct sales force. The company expects CE Mark approval by the first quarter of next year...